Dfine Bio-innovations

Bengaluru, India Founded: 2020 • Age: 6 yrs
Manufactures coagulation analyzers and high-quality consumables for medical diagnostics laboratories worldwide.

About Dfine Bio-innovations

Dfine Bio-innovations is a Healthcare company based in Bengaluru (India) founded in 2020 by Prathap M, Divya Acharya, Lokesh Murthy, and Afser Shariff. It manufactures coagulation analyzers and high-quality consumables for medical diagnostics laboratories worldwide. It operates on a B2B model. The company has 1 employees. Its Indian entity Dfine Bioinnovations Private Limited reported revenue of β‚Ή1.56 Cr. Dfine Bio-innovations offers products and services including Zeta-1, Zeta-2, and Consumables. Its focus areas include Diagnostics Tech, Coagulation Analysis, Lab Equipment and Consumables Manufacturing.

Company details

Dfine Bioinnovations, based in Bangalore, India, focuses on creating innovative diagnostic technologies for healthcare. They produce semi-automatic coagulation analyzers like Zeta-1 and upcoming Zeta-2, along with consumables such as buffer bottles and cuvettes. The company emphasizes cost-effective, indigenous solutions for small to mid-size labs, ensuring accuracy in tests like PTAPTT. Their products are validated and patented, serving global laboratories with reliable diagnostic tools.

  • Headquarters Bengaluru, India
  • Employees 1
  • Founders Prathap M, Divya Acharya, Lokesh Murthy, Afser Shariff
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website dfinebio.in
  • Social LinkedIn Instagram
  • Legal Name Dfine Bioinnovations Private Limited
  • Date of Incorporation 10 Dec, 2020
  • Jurisdiction Bangalore, Karnataka, India
Key Metrics
  • Annual Revenue
    ₹1.56 Cr

    FY 2025 · +356% YoY

  • Net Loss
    -₹3.9 Lakh

    FY 2025 · -2% margin

  • EBITDA
    -₹1.2 Lakh

    FY 2025 · -1% margin

  • Employee Count
    1

Products & Services of Dfine Bio-innovations

Dfine Bio-innovations offers a comprehensive portfolio of products and services, including Zeta-1, Zeta-2, and Consumables.

Zeta-1
Coagulation Analyzer

Semi-automatic device for accurate blood coagulation diagnostic tests

Zeta-2
Coagulation Analyzer

Upcoming two-channel analyzer for efficient lab throughput

Consumables
Diagnostic Supplies

High-quality items like cuvettes and buffer bottles for lab equipment

Board of directors of Dfine Bioinnovations Private Limited (Dfine Bio-innovations)

Dfine Bioinnovations Private Limited is the primary company behind Dfine Bio-innovations. The board of Dfine Bioinnovations Private Limited currently have 5 directors; the longest-serving is Afser Shariff, appointed in 2020.

DirectorDesignationAppointedTenureEntity
Afser Shariff
DIN 05180188
Director10 Dec 20205 yrs 10 moDfine Bioinnovations Private Limited
Divya Acharya
DIN 06564706
Managing Director10 Dec 20205 yrs 10 moDfine Bioinnovations Private Limited
Mahadevappa Prathap
DIN 08992163
Director10 Dec 20205 yrs 10 moDfine Bioinnovations Private Limited
Kirugavalu Murugendraswamy Lokesh Murthy
DIN 08992142
Director10 Dec 20205 yrs 10 moDfine Bioinnovations Private Limited
Srirampura Gowdappa Sudheendra
DIN 10823062
Director29 Oct 20241 yr 11 moDfine Bioinnovations Private Limited

People of Dfine Bio-innovations

4 people are tracked at Dfine Bio-innovations (4 in leadership); the tracked headcount is 1.

NameRoleGroup
Prathap M
Co-FounderLeadership
Co-FounderLeadership
Co-FounderLeadership
Co-FounderLeadership
Premium access

Complete people profiles for Dfine Bio-innovations

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Dfine Bio-innovations

Figures of Dfine Bioinnovations Private Limited, the primary company behind Dfine Bio-innovations, for FY 2025. Revenue was ₹1.56 Cr (+356% year on year). Net loss was -₹3.9 Lakh (-2% margin). EBITDA was -₹1.2 Lakh (-1% margin). Revenue has grown at a compounded annual rate of +137% over three years.

  • ₹1.56 CrRevenue · FY 2025 · +356% YoY
  • -₹3.9 LakhNet loss · -2% margin
  • -₹1.2 LakhEBITDA · -1% margin
  • ₹10.5 LakhPaid-up capital
  • +137%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Dfine Bioinnovations Private Limited are on its company page.

Premium access

Detailed financial statements for Dfine Bio-innovations

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Dfine Bio-innovations

Dfine Bio-innovations was founded in 2020.

Dfine Bio-innovations is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Dfine Bio-innovations has 1 employees.

The primary company behind Dfine Bio-innovations, Dfine Bioinnovations Private Limited, reported revenue of β‚Ή1.56 Cr for FY 2025, up 356% year on year.

Dfine Bioinnovations, based in Bangalore, India, focuses on creating innovative diagnostic technologies for healthcare. They produce semi-automatic coagulation analyzers like Zeta-1 and upcoming Zeta-2, along with consumables such as buffer bottles and cuvettes. The company emphasizes cost-effective, indigenous solutions for small to mid-size labs, ensuring accuracy in tests like PTAPTT. Their products are validated and patented, serving global laboratories with reliable diagnostic tools.

Dfine Bio-innovations offers Zeta-1, Zeta-2, and Consumables.

Dfine Bio-innovations operates through Dfine Bioinnovations Private Limited.

The legal entities of Dfine Bio-innovations currently have 5 directors, including Afser Shariff, Divya Acharya, Srirampura Gowdappa Sudheendra and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available